Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Flow Cytometers
    • 1.2.1.2 NGS Systems
    • 1.2.1.3 PCR Instruments
    • 1.2.1.4 Spectrophotometers
    • 1.2.1.5 Microscopes
    • 1.2.1.6 Cell Counters
    • 1.2.1.7 HCS Systems
    • 1.2.1.8 Cell Microarrays
    • 1.2.1.9 Others
  • 1.2.2 by Application
    • 1.2.2.1 Noninvasive Prenatal Diagnosis
    • 1.2.2.2 In Vitro Fertilization
    • 1.2.2.3 Circulating Tumor Cell Detection
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Flow Cytometers Market, 2013-2018
  • 4.1.2 NGS Systems Market, 2013-2018
  • 4.1.3 PCR Instruments Market, 2013-2018
  • 4.1.4 Spectrophotometers Market, 2013-2018
  • 4.1.5 Microscopes Market, 2013-2018
  • 4.1.6 Cell Counters Market, 2013-2018
  • 4.1.7 HCS Systems Market, 2013-2018
  • 4.1.8 Cell Microarrays Market, 2013-2018
  • 4.1.9 Others Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Flow Cytometers Market Forecast, 2019-2024
  • 4.2.2 NGS Systems Market Forecast, 2019-2024
  • 4.2.3 PCR Instruments Market Forecast, 2019-2024
  • 4.2.4 Spectrophotometers Market Forecast, 2019-2024
  • 4.2.5 Microscopes Market Forecast, 2019-2024
  • 4.2.6 Cell Counters Market Forecast, 2019-2024
  • 4.2.7 HCS Systems Market Forecast, 2019-2024
  • 4.2.8 Cell Microarrays Market Forecast, 2019-2024
  • 4.2.9 Others Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Noninvasive Prenatal Diagnosis Market, 2013-2018
  • 5.1.2 In Vitro Fertilization Market, 2013-2018
  • 5.1.3 Circulating Tumor Cell Detection Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Noninvasive Prenatal Diagnosis Market Forecast, 2019-2024
  • 5.2.2 In Vitro Fertilization Market Forecast, 2019-2024
  • 5.2.3 Circulating Tumor Cell Detection Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 Merck KGaA (Germany)
• 8.2 Becton, Dickinson and Company (U.S.)
• 8.3 Promega Corporation (U.S.)
• 8.4 Danaher Corporation (U.S.)
• 8.5 General ElectricCompany (U.K.)
• 8.6 Thermo Fisher Scientific Inc. (U.S.)
• 8.7 Miltenyi Biotec (Germany)
• 8.8 Illumina, Inc. (U.S.)
• 8.9 Bio-Rad Laboratories, Inc.(U.S.)
• 8.10 Fluidigm Corporation (U.S.)
• 8.11 NanoString Technologies, Inc. (U.S.)
• 8.12 Agilent Technologies (U.S.)
• 8.13 Abcam Plc (U.S.)
• 8.14 NuGEN Technologies Inc. (U.S.)
• 8.15 LumaCyte (U.S.)
• 8.16 PluriSelect Life Science UG & Co. KG (Germany)
• 8.17 Sysmex Partec(U.S.)
• 8.18 Bio-Techne Corporation (U.S.)

9 Conclusion

Summary
The global Microbial Cells Analysis Instrument market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Flow Cytometers
NGS Systems
PCR Instruments
Spectrophotometers
Microscopes
Cell Counters
HCS Systems
Cell Microarrays
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Merck KGaA (Germany)
Becton, Dickinson and Company (U.S.)
Promega Corporation (U.S.)
Danaher Corporation (U.S.)
General ElectricCompany (U.K.)
Thermo Fisher Scientific Inc. (U.S.)
Miltenyi Biotec (Germany)
Illumina, Inc. (U.S.)
Bio-Rad Laboratories, Inc.(U.S.)
Fluidigm Corporation (U.S.)
NanoString Technologies, Inc. (U.S.)
Agilent Technologies (U.S.)
Abcam Plc (U.S.)
NuGEN Technologies Inc. (U.S.)
LumaCyte (U.S.)
PluriSelect Life Science UG & Co. KG (Germany)
Sysmex Partec(U.S.)
Bio-Techne Corporation (U.S.)
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Noninvasive Prenatal Diagnosis
In Vitro Fertilization
Circulating Tumor Cell Detection
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa